WHO ICTRP trial
Different B cell target CART cells for sequential treatment of relapsed and…
ChiCTR1900020980 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR1900020980 |
|---|---|
| Public title | Different B cell target CART cells for sequential treatment of relapsed and refractory adult invasive B cell lymphoma |
| Scientific title | Different B cell target CART cells for sequential treatment of relapsed and refractory adult invasive B cell lymphoma |
| Primary sponsor | Beijing Boren Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Observational study |
| Phase | I (Phase I study) |
| Countries | China |
| Conditions | relapsed and refractory adult invasive B cell lymphoma |
| Interventions | Case series:CART cell sequential treatment |
| Registration date | Jan 23, 2019 |
| Target size | Case series:20 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: